NO911415L - Fremgangsmaate for fremstilling av difluorglutaminsyrekonjugater med folater og anti-folater. - Google Patents

Fremgangsmaate for fremstilling av difluorglutaminsyrekonjugater med folater og anti-folater.

Info

Publication number: NO911415L
Authority: NO; Norway
Prior art keywords: folates; difluorlutamic; procedure; preparation; acid conjugates
Prior art date: 1990-04-12

Application number

NO91911415A

Other languages

English (en)

Norwegian (no)

Other versions

NO911415D0 (no

Inventor

Philippe Bey

James K Coward

John J Mcguire

Original Assignee

Health Research Inc

Merrell Dow Pharma

Univ Michigan

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-04-12

Filing date

1991-04-11

Publication date

1991-10-14

1991-04-11 Application filed by Health Research Inc, Merrell Dow Pharma, Univ Michigan filed Critical Health Research Inc

1991-04-11 Publication of NO911415D0 publication Critical patent/NO911415D0/no

1991-10-14 Publication of NO911415L publication Critical patent/NO911415L/no

Links

229940127074 antifolate Drugs 0.000 title abstract 2
239000004052 folic acid antagonist Substances 0.000 title abstract 2
150000002224 folic acids Chemical class 0.000 title abstract 2
239000002253 acid Substances 0.000 title 1
COKJHIVDQXTJKI-VKHMYHEASA-N (2s)-2-(difluoroamino)pentanedioic acid Chemical compound OC(=O)CC[C@H](N(F)F)C(O)=O COKJHIVDQXTJKI-VKHMYHEASA-N 0.000 abstract 1
201000009030 Carcinoma Diseases 0.000 abstract 1
206010028980 Neoplasm Diseases 0.000 abstract 1
206010039491 Sarcoma Diseases 0.000 abstract 1
230000003432 anti-folate effect Effects 0.000 abstract 1
201000010099 disease Diseases 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
235000019152 folic acid Nutrition 0.000 abstract 1
208000032839 leukemia Diseases 0.000 abstract 1
201000001441 melanoma Diseases 0.000 abstract 1
230000009826 neoplastic cell growth Effects 0.000 abstract 1
230000001613 neoplastic effect Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D475/00—Heterocyclic compounds containing pteridine ring systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D475/00—Heterocyclic compounds containing pteridine ring systems
- C07D475/06—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4
- C07D475/08—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Oncology (AREA)
Hematology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Peptides Or Proteins (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Saccharide Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

NO91911415A 1990-04-12 1991-04-11 Fremgangsmaate for fremstilling av difluorglutaminsyrekonjugater med folater og anti-folater. NO911415L (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US07/508,873 US5286726A (en)	1990-04-12	1990-04-12	Difluoroglutamic acid conjugates with folates and anti-folates for the treatment of neoplastic diseases

Publications (2)

Publication Number	Publication Date
NO911415D0 NO911415D0 (no)	1991-04-11
NO911415L true NO911415L (no)	1991-10-14

Family

ID=24024425

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO91911415A NO911415L (no)	1990-04-12	1991-04-11	Fremgangsmaate for fremstilling av difluorglutaminsyrekonjugater med folater og anti-folater.

Country Status (17)

Country	Link
US (1)	US5286726A (fr)
EP (1)	EP0451836B1 (fr)
JP (1)	JP2894576B2 (fr)
KR (1)	KR910018383A (fr)
CN (1)	CN1057653A (fr)
AT (1)	ATE132149T1 (fr)
AU (1)	AU631055B2 (fr)
CA (1)	CA2039855C (fr)
DE (1)	DE69115744T2 (fr)
ES (1)	ES2082029T3 (fr)
FI (1)	FI911788L (fr)
HU (1)	HUT57793A (fr)
IE (1)	IE911234A1 (fr)
IL (1)	IL97815A0 (fr)
NO (1)	NO911415L (fr)
PT (1)	PT97337B (fr)
ZA (1)	ZA912555B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9205907D0 (en) *	1992-03-18	1992-04-29	Cancer Res Inst Royal	Anti-cancer compounds
WO1993020075A1 (fr) *	1992-04-01	1993-10-14	The University Of Sydney	N5-desazapterines substituees en position 8, utilisees comme antifolates
AU4220193A (en) *	1992-04-29	1993-11-29	Sri International	Deazaaminopterins for treatment of inflammation
US5547954A (en) *	1994-05-26	1996-08-20	Fmc Corporation	2,4-Diamino-5,6-disubstituted-and 5,6,7-trisubstituted-5-deazapteridines as insecticides
US6323205B1 (en) *	1996-07-17	2001-11-27	Sloan-Kettering Institute For Cancer Research	Combinations of 10-propargyl-10-deazaaminopterin and taxols and methods of using same in the treatment of tumors
DE19830599A1 (de) *	1998-07-09	2000-01-13	Basf Ag	Verfahren zur stereoselektiven Herstellung von Grignardverbindungen und deren Verwendung
CN101646639A (zh)	2007-04-11	2010-02-10	默克阿泼洛发股份公司	18f-标记的叶酸
WO2008125615A1 (fr) *	2007-04-11	2008-10-23	Merck Eprova Ag	Folates marqués au 18f
US9901578B2 (en)	2007-08-17	2018-02-27	Allos Therapeutics, Inc.	Combination of 10-propargyl-10-deazaaminopterin and erlotinib for the treatment of non-small cell lung cancer
US20090048262A1 (en) *	2007-08-17	2009-02-19	Allos Therapeutics, Inc.	Combination of 10-propargyl-10-deazaaminopterin and erlotinib for the treatment of non-small cell lung cancer
US20100248249A1 (en) *	2007-08-17	2010-09-30	Allos Therapeutics, Inc.	Methods for Assessing Cancer for Increased Sensitivity to 10-Propargyl-10-Deazaaminopterin by Assessing Egfr Levels
CA2736861C (fr)	2008-10-10	2017-11-14	Roger Schibli	Folates marques au 18f en tant que radiotraceurs de tep
WO2011096947A1 (fr) *	2010-02-02	2011-08-11	Allos Therapeutics, Inc.	Diastéréo-isomères optiquement purs de 10-propargyl-10-deazaaminoptérine, et leurs procédés d'utilisation

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2520392A (en) *	1947-06-27	1950-08-29	Flenghi Louis	Disk and pin game
US4393064A (en) *	1976-03-05	1983-07-12	Sri International	Process and composition for treatment of leukemia and process for preparing the same
EP0031237B1 (fr) *	1979-12-19	1984-10-17	National Research Development Corporation	Dérivés de la quinazoline, procédés pour leur préparation, compositions les contenant et leur utilisation comme agents anticancéreux
US4853221A (en) *	1980-11-13	1989-08-01	Warner-Lambert Company	Method for treating non-small cell lung cancer, head and neck cancers and breast cancer
US4628089A (en) *	1982-01-11	1986-12-09	Southern Research Institute	Pyrido(2,3-D)pyrimidines
US4460591A (en) *	1982-08-26	1984-07-17	Sri International	8,10-Dideazaminopterins
US4584375A (en) *	1984-08-21	1986-04-22	Rensselaer Polytechnic Institute	Fluorine-containing antifolates incapable of polyglutamate formation
US4628090A (en) *	1984-08-21	1986-12-09	Rensselaer Polytechnic Institute	Fluorine-containing antifolates incapable of polyglutanayte formation related compounds
US5026851A (en) *	1985-03-08	1991-06-25	The Trustees Of Princeton University	Pyrido[2,3-]pyrimidine derivatives
GB8513754D0 (en) *	1985-05-31	1985-07-03	Jones T R	Anti-cancer quinazoline derivatives
JPS6281385A (ja) *	1985-10-02	1987-04-14	Shionogi & Co Ltd	新規メトトレキサ−ト誘導体
GB8607683D0 (en) *	1986-03-27	1986-04-30	Ici Plc	Anti-tumor agents
US5223620A (en) *	1988-04-01	1993-06-29	Takeda Chemical Industries, Ltd.	Pyrido[2,3-d]pyrimidine compounds useful as intermediates
GB8809978D0 (en) *	1988-04-27	1988-06-02	Ici Plc	Anti-tumour agents
US4882333A (en) *	1988-05-25	1989-11-21	The Trustess Of Princeton University	N-(5,6,7,8-tetrahydropyrido[2,3-d]pyrimidin-6-yl-alkanoyl)-glutamic acid derivatives
WO1990000172A1 (fr) *	1988-07-01	1990-01-11	Sloan-Kettering Institute For Cancer Research	Analogues de 5-deaza-5,7-aminopterine bisubstituee
EP0388456A1 (fr) *	1988-09-16	1990-09-26	Sri International	Derives de l'acide 8,10-dideazatetrahydrofolique
CA2001458A1 (fr) *	1989-08-14	1991-02-14	James R. Piper	5-methyl-5-deaza-10-propargylaminopterine
US4996207A (en) *	1990-01-18	1991-02-26	Nair Madhavan G	Three new non-polyglutamatable deazaaminopterins
US5066828A (en) *	1990-04-12	1991-11-19	Merrell Dow Pharmaceuticals Inc.	Difluoroglutamic acid conjugates with folates and anti-folates for the treatment of neoplastic diseases

1990
- 1990-04-12 US US07/508,873 patent/US5286726A/en not_active Expired - Lifetime
1991
- 1991-04-05 ZA ZA912555A patent/ZA912555B/xx unknown
- 1991-04-05 CA CA002039855A patent/CA2039855C/fr not_active Expired - Fee Related
- 1991-04-09 AU AU74175/91A patent/AU631055B2/en not_active Ceased
- 1991-04-10 IL IL97815A patent/IL97815A0/xx unknown
- 1991-04-11 IE IE123491A patent/IE911234A1/en unknown
- 1991-04-11 HU HU911193A patent/HUT57793A/hu unknown
- 1991-04-11 EP EP91105768A patent/EP0451836B1/fr not_active Expired - Lifetime
- 1991-04-11 NO NO91911415A patent/NO911415L/no unknown
- 1991-04-11 AT AT91105768T patent/ATE132149T1/de not_active IP Right Cessation
- 1991-04-11 KR KR1019910005788A patent/KR910018383A/ko not_active Withdrawn
- 1991-04-11 CN CN91102295A patent/CN1057653A/zh active Pending
- 1991-04-11 PT PT97337A patent/PT97337B/pt not_active IP Right Cessation
- 1991-04-11 DE DE69115744T patent/DE69115744T2/de not_active Expired - Fee Related
- 1991-04-11 ES ES91105768T patent/ES2082029T3/es not_active Expired - Lifetime
- 1991-04-12 FI FI911788A patent/FI911788L/fi not_active Application Discontinuation
- 1991-04-12 JP JP3106389A patent/JP2894576B2/ja not_active Expired - Fee Related

Also Published As

Publication number	Publication date
PT97337A (pt)	1992-01-31
IL97815A0 (en)	1992-06-21
AU7417591A (en)	1991-10-17
NO911415D0 (no)	1991-04-11
DE69115744D1 (de)	1996-02-08
HUT57793A (en)	1991-12-30
CA2039855C (fr)	2001-08-21
EP0451836A3 (en)	1992-07-01
JPH04234854A (ja)	1992-08-24
KR910018383A (ko)	1991-11-30
HU911193D0 (en)	1991-10-28
US5286726A (en)	1994-02-15
EP0451836B1 (fr)	1995-12-27
JP2894576B2 (ja)	1999-05-24
FI911788A7 (fi)	1991-10-13
PT97337B (pt)	1998-08-31
CA2039855A1 (fr)	1991-10-13
DE69115744T2 (de)	1996-05-30
FI911788L (fi)	1991-10-13
IE911234A1 (en)	1991-10-23
ES2082029T3 (es)	1996-03-16
ZA912555B (en)	1992-04-29
ATE132149T1 (de)	1996-01-15
CN1057653A (zh)	1992-01-08
FI911788A0 (fi)	1991-04-12
AU631055B2 (en)	1992-11-12
EP0451836A2 (fr)	1991-10-16

Publication	Publication Date	Title
NO911415D0 (no)	1991-04-11	Fremgangsmaate for fremstilling av difluorglutaminsyrekonjugater med folater og anti-folater.
GR20010300006T1 (en)	2001-02-28	Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas
EP0335901A4 (en)	1990-11-28	Methods and compositions for the treatment of non-ige-mediated diseases
UA39158C2 (uk)	2001-06-15	Похідні n4-оксикарбоніл-5'-дезокси-5-фторцитидину та фармацевтичний препарат на їх основі
ATE334668T1 (de)	2006-08-15	Pharmazeutische zusammensetzung zur behandlung von neurologischen und neuropsychiatrischen erkrankungen
NO911418D0 (no)	1991-04-11	Fremgangsmaate for fremstilling av difluorglutaminsyrekonjugater med folater og anti-folater.
ATE91628T1 (de)	1993-08-15	Sauerwiderstehender fibroblast-wachstumsfaktor, zubereitung zur behandlung von magen-darmweggeschw¨rkrankheiten.
DK465488A (da)	1989-03-15	Farmaceutisk praeparat indeholdende en triazol-forbindelse
RU1833372C (ru)	1993-08-07	Cпocoб пoлучehия пpoизboдhыx 2,4,5-зameщehhыx бehзoлa
EP0328634A4 (en)	1991-08-21	Pharmaceutical compositions for the treatment of psoriasis
ATE372774T1 (de)	2007-09-15	Medikament zur verabreichung von amifostin und verwandten wirkstoffen
ATE151776T1 (de)	1997-05-15	Cytotoxische und antivirale verbindung
TR199802200A2 (xx)	1999-05-21	S�lfonamid s�bstit�e edilmi� benzopiran t�revleri, �retilme y�ntemi.
AU2001292698A1 (en)	2002-04-15	Hexahydropyrazino `1'2' : 1, 6!- pyrido `3, 4-b! indole-1, 4-dione derivatives for the treatment of cardiovascular disorders and erectile disfunction
DE59101818D1 (de)	1994-07-14	Arzneimittelzubereitung, enthaltend Stigmasta-4-en-3-on sowie deren Verwendung.
TR199701605A2 (xx)	1998-07-21	S�lfonamid-substit�e edilmi� bile�ikler
NO945094L (no)	1995-07-03	Anvendelse av bradykininantagonister for fremstilling av legemidler for behandling av virussykdommer
DK0495226T3 (da)	1995-11-27	Anvendelse af 3-aryl-5-alkylthio-4H-1,2,4-triazoler til behandling af hyperrefleksi som følge af spinaltrauma
FI890173L (fi)	1989-01-13	Isoxazoler med nootropisk verkan.
ATE121935T1 (de)	1995-05-15	D-asparaginsäure-beta-hydroxamat zur behandlung viraler infektionen und tumoren.
DE3373907D1 (en)	1987-11-05	N-acyl derivatives of dipeptides, their manufacture and use in treating diseases, and means therefor